Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × INDUSTRY × Melphalan × Clear all

Phase

Phase 3 8 Phase 2 8 Phase 1/2 8 Phase 1 4 Phase NA 1 Phase 4 1

Status

Sponsor Class

OTHER 24 NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Mammography 12 Standard of Care 8 Radiofrequency Ablation 7 Colonoscopy 7 Uterine Myomectomy 6 Robotic Surgical Procedures 6 Drug Delivery Systems 6 Blood Specimen Collection 6 Proton Therapy 5 Inositol 5 Cryosurgery 5 Colposcopy 5 Therapeutics 4 Leukapheresis 4 Food 4 Drug Therapy 4 CF regimen 4 Brachytherapy 4 Biopsy 4 pegylated granulocyte colony-stimulating factor 3 Uterine Artery Embolization 3 Sunitinib 3 Radiotherapy 3 Paclitaxel 3 Dietary Supplements 3 Control Groups 3 Cisplatin 3 Biopsy, Large-Core Needle 3 temsirolimus 2 exemestane 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01572688 2012-08-02

MM

Shandong Lanjin Pharmaceuticals Co.,Ltd

Phase NA Unknown

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡